F-1: Park Ha Biological Technology Files for $7.2 Million IPO on Nasdaq

Park Ha Biological Technology Co., Ltd. seeks to raise $7.2 million through an initial public offering of 1,200,000 ordinary shares, aiming for a Nasdaq listing under the symbol PHH.

Summary

• Park Ha Biological Technology Co., Ltd., a Cayman Islands holding company, has filed for an initial public offering (IPO) to list its ordinary shares on the Nasdaq Capital Market.
• The company plans to offer 1,200,000 ordinary shares with an expected price range of $5.00 to $7.00 per share, potentially raising $7.2 million at the midpoint.
• Park Ha Cayman operates through its subsidiaries in China, specializing in skincare and cosmetic products under the Park Ha brand.
• The company's revenue streams include product sales and franchise fees, with a recent shift towards a higher proportion of revenue from franchise fees.
• The IPO proceeds are intended for expanding directly-owned stores, purchasing product patents, and acquiring ingredients suppliers.
• Investors are cautioned about risks associated with the company's holding company structure, operations in China, and potential regulatory changes.
• The company's CEO will retain significant voting power post-IPO, potentially influencing corporate decisions.
• Park Ha Cayman is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company shows growth in some areas, there are also significant risks and challenges, including declining revenue and net income in the recent period, regulatory uncertainties, and intense competition. The company's reliance on a few major customers and suppliers also adds to the risk.

Positives

• The company has a research and development center, Park Ha Jiangsu, and collaborates with research institutes.
• The company has a franchise model with 43 franchisees as of April 30, 2024.
• The company intends to strengthen its brand awareness through social media platforms.
• The company plans to improve its training practice by opening vocational training schools.
• The company aims to improve supply chain capacity by partnering with additional third-party manufacturers and distribution centers.

Negatives

• The company's revenue decreased for the six months ended April 30, 2024, compared to the same period in 2023.
• The company faces intense competition in the skincare industry.
• The company relies on third-party manufacturers for product formulas.
• The company has a limited operating history.
• The company is subject to legal and operational risks associated with doing business in China.

Risks

• The company's ability to transfer cash out of China may be restricted by the PRC government.
• The company may be affected by changes in PRC political, economic, and governmental policies.
• The company may be subject to civil complaints and regulatory actions under PRC laws relating to labor, social insurance, and housing provident funds.
• The company's Ordinary Shares may be prohibited from trading on a national exchange under the HFCAA if the PCAOB is unable to inspect the company's auditors.
• The company may be subject to cybersecurity review by the CAC.
• The company's success depends on the continued popularity of its products and its ability to anticipate and respond to changes in industry trends and consumer preferences.
• The company may be unable to manage its growth effectively or efficiently.
• The company may be subject to infringement claims of intellectual property rights or other rights of third parties.
• The company relies on a limited number of suppliers.
• The company derives a significant portion of its revenue from a few major customers.
• The company is, and will continue to be, a controlled company within the meaning of the Nasdaq Listing Rules.
• The trading price of the Ordinary Shares is likely to be volatile.

Future Outlook

The company intends to retain most, if not all, of its available funds and any future earnings after this offering to the development and growth of the business in China and does not expect to pay dividends in the foreseeable future.

Management Comments

• Our management monitors the cash position of each entity within our organization regularly and prepare monthly budgets to ensure each entity has the necessary funds to fulfill its obligation for the foreseeable future and to ensure adequate liquidity.
• In the event that there is any current or potential liquidity issue, it will be reported to our Chief Financial Officer and subject to approval by our board of directors, we will enter into an intercompany loan for the applicable subsidiary.

Industry Context

The company operates in the competitive skincare and cosmetics industry in China, facing competition from both multinational and domestic brands. The company seeks to differentiate itself through its brand, product quality, and social marketing model.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the document mentions competitors such as Fanwenhua, DR PLANT, and Beauty Farm, each of whom has over 100 franchisees nationwide.
• These competitors have longer operating histories and relatively higher market share than Park Ha.

Related Party Transactions

• The company has related party transactions with key individuals, including loans and advances.
• These transactions are disclosed in the document.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Shareholders may face difficulties in protecting their interests due to the company's incorporation in the Cayman Islands.
• Shareholders may be subject to U.S. federal income tax consequences if the company is classified as a PFIC.
• Employees may be affected by changes in compensation and benefits.
• Customers may benefit from the company's expansion and new product development.
• Suppliers may be affected by the company's plans to acquire ingredients suppliers.

Next Steps

• The company needs to obtain Nasdaq's final approval for its listing application.
• The company intends to use the proceeds from this offering for expanding the scale of its directly-owned stores, purchasing existing product patents, and acquiring its ingredients suppliers.
• The company will need to monitor and comply with evolving PRC regulations.
• The company will need to manage its growth effectively and efficiently.
• The company will need to continue to innovate and develop new products to maintain its competitive edge.

Key Dates

Keywords

IPO, skincare, cosmetics, franchise, China, Nasdaq, PHH, beauty, technology, biological